Elijah K Goldberg1, Ellen B Fung2. 1. Children's Hospital Oakland Research Institute, Oakland, CA, USA. 2. Children's Hospital Oakland Research Institute, Oakland, CA, USA; Department of Hematology, UCSF Benioff Children's Hospital Oakland, Oakland, CA, USA. Electronic address: efung@mail.cho.org.
Abstract
INTRODUCTION: Visceral fat, also known as visceral adipose tissue (VAT), has been the focus of intensive research over the past several yr, as ground breaking studies have investigated its possible role in predicting long-term cardiac dysfunction, hypertension, and diabetes. Historically, magnetic resonance imaging and computed tomography were the instruments of choice for visceral fat quantification. However, with the introduction of visceral fat assessment software for Dual-energy X-ray Absorptiometry (DXA) scanners, DXA's use for VAT assessment has become increasingly common. To effectively utilize DXA in future VAT research studies, information about their precision and accuracy must be known. This study provides novel information regarding the precision of the Hologic Horizon DXA scanner in the assessment of VAT. METHODS: Sixty individuals (32.7 ± 17.1 yr, 51% male, 40% with body mass index (BMI) > 25 kg/m2) above the age of 16 years were recruited to participate in this study. Subjects found to be pregnant, have a lumbar vertebral compression fracture, nonremovable metal implants in the abdomen, or scoliosis/lordosis/kyphosis were excluded from the study. All subjects underwent 3 consecutive whole body scans on a Hologic Horizon A DXA scanner. RESULTS: VAT mass ranged from 102 g to 1454 g. VAT precision improved with increasing BMI (p = 0.025): coefficient of variation (%CV) was 15.2% for underweight subjects (n = 2), 7.1% for healthy subjects (n = 34), 6.4% for overweight subjects (n = 18), and 4.7% for obese subjects (n = 6). CONCLUSIONS: VAT measurement by Hologic DXA displays a satisfactory level of precision in individuals with a BMI of >18.5 kg/m2. Precision was found to be higher in those with the greatest risk of cardio-metabolic dysfunction (individuals with high VAT). Due to its low cost, brief examination time, noninvasiveness, and limited radiation exposure, DXA may be considered the tool of choice for VAT determination in future studies.
INTRODUCTION: Visceral fat, also known as visceral adipose tissue (VAT), has been the focus of intensive research over the past several yr, as ground breaking studies have investigated its possible role in predicting long-term cardiac dysfunction, hypertension, and diabetes. Historically, magnetic resonance imaging and computed tomography were the instruments of choice for visceral fat quantification. However, with the introduction of visceral fat assessment software for Dual-energy X-ray Absorptiometry (DXA) scanners, DXA's use for VAT assessment has become increasingly common. To effectively utilize DXA in future VAT research studies, information about their precision and accuracy must be known. This study provides novel information regarding the precision of the Hologic Horizon DXA scanner in the assessment of VAT. METHODS: Sixty individuals (32.7 ± 17.1 yr, 51% male, 40% with body mass index (BMI) > 25 kg/m2) above the age of 16 years were recruited to participate in this study. Subjects found to be pregnant, have a lumbar vertebral compression fracture, nonremovable metal implants in the abdomen, or scoliosis/lordosis/kyphosis were excluded from the study. All subjects underwent 3 consecutive whole body scans on a Hologic Horizon A DXA scanner. RESULTS: VAT mass ranged from 102 g to 1454 g. VAT precision improved with increasing BMI (p = 0.025): coefficient of variation (%CV) was 15.2% for underweight subjects (n = 2), 7.1% for healthy subjects (n = 34), 6.4% for overweight subjects (n = 18), and 4.7% for obese subjects (n = 6). CONCLUSIONS: VAT measurement by Hologic DXA displays a satisfactory level of precision in individuals with a BMI of >18.5 kg/m2. Precision was found to be higher in those with the greatest risk of cardio-metabolic dysfunction (individuals with high VAT). Due to its low cost, brief examination time, noninvasiveness, and limited radiation exposure, DXA may be considered the tool of choice for VAT determination in future studies.
Authors: Megan P Rothney; Yi Xia; Wynn K Wacker; Francois-Pierre Martin; Maurice Beaumont; Serge Rezzi; Vittorio Giusti; David L Ergun Journal: Obesity (Silver Spring) Date: 2013-01 Impact factor: 5.002
Authors: Peter T Katzmarzyk; Frank L Greenway; Steven B Heymsfield; Claude Bouchard Journal: Obesity (Silver Spring) Date: 2013-08-13 Impact factor: 5.002
Authors: Miriam A Bredella; Corey M Gill; Leigh K Keating; Martin Torriani; Ellen J Anderson; Mark Punyanitya; Kevin E Wilson; Thomas L Kelly; Karen K Miller Journal: Obesity (Silver Spring) Date: 2013-06-13 Impact factor: 5.002
Authors: Kenan Direk; Marina Cecelja; William Astle; Phil Chowienczyk; Tim D Spector; Mario Falchi; Toby Andrew Journal: BMC Cardiovasc Disord Date: 2013-04-03 Impact factor: 2.298
Authors: Simon Higgins; Babette S Zemel; Philip R Khoury; Elaine M Urbina; Joseph M Kindler Journal: Pediatr Obes Date: 2021-10-19 Impact factor: 4.000
Authors: Grace Huang; Karol Pencina; Zhuoying Li; Caroline M Apovian; Thomas G Travison; Thomas W Storer; Thiago Gagliano-Jucá; Shehzad Basaria; Shalender Bhasin Journal: J Gerontol A Biol Sci Med Sci Date: 2021-05-22 Impact factor: 6.053
Authors: Y Kutsenko; A Barreda; A Toval; D Garrigos; M Martínez-Morga; B Ribeiro Do Couto; J L Ferran Journal: Sci Rep Date: 2021-05-12 Impact factor: 4.379
Authors: Joaquín Sanchis-Moysi; José Antonio Serrano-Sánchez; Juan José González-Henríquez; José A L Calbet; Cecilia Dorado Journal: Front Pediatr Date: 2019-08-20 Impact factor: 3.418